← Eichor
Condition: Inflammatory Disorder Of Immune System Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Inflammatory Disorder Of Immune System

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks
NA · 1 location(s) · Pierre Fabre Dermo Cosmetique · NCT07014007Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT03913962Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, a
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT03510442A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg)
Phase 3 · 129 location(s) · Sanofi · NCT06290141Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-medi
Phase N/A · 4 location(s) · Meyer Children's Hospital IRCCS · NCT06862843A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Phase 1 · 14 location(s) · CRISPR Therapeutics · NCT06925542The Predictive Role of Immune-inflammatory Biomarkers and Their Interaction With the Oxytocin System in Trauma-related P
Phase N/A · 1 location(s) · Shalvata Mental Health Center · NCT06348472IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies
Phase 2 · 1 location(s) · Endeavor Health · NCT04153422Determinants of Chronic Inflammatory Skin Disease Trajectories
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT05928169Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
Phase N/A · 1 location(s) · University of Bonn · NCT06460142FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Phase 1 · 5 location(s) · Pfizer · NCT06564389Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Phase N/A · 23 location(s) · argenx · NCT07264426China National Registry of Neuro-Inflammatory Diseases
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05154370A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
Phase 1 · 2 location(s) · Beijing GoBroad Hospital · NCT06980597PET-Based Imaging of Radiolabeled CIT-013
Phase 2 · 1 location(s) · Citryll BV · NCT07147959Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Peking University Third Hospital · NCT06828042Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT07022197A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
Phase N/A · 11 location(s) · BioMarin Pharmaceutical · NCT06305234Biobank for Inflammatory Chronic Diseases and Osteoporosis
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05039216Oxidative Stress in Autoimmune Rheumatic Diseases
Phase N/A · 1 location(s) · University of Thessaly · NCT07536529Mayo AVC Registry and Biobank
Phase N/A · 2 location(s) · Mayo Clinic · NCT03049254A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants Wit
Phase 1 · 37 location(s) · AstraZeneca · NCT06916806Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arr
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06591260A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Phase 1 · 19 location(s) · GlaxoSmithKline · NCT07371468Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
Phase 3 · 33 location(s) · Mayo Clinic · NCT07100990Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Mu
Phase 2 · 2 location(s) · Queen Mary University of London · NCT05418010Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Phase 2 · 8 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07103746
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.